Go Pro

Insider Selling: IBEX (NASDAQ:IBEX) Insider Sells 2,500 Shares

IBEX logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • IBEX insider Paul Inson sold 2,500 shares at an average price of $40.07, generating $100,175 and reducing his ownership by 8.41%. He had also sold 2,274 shares earlier in the week.
  • IBEX’s latest quarterly results modestly exceeded expectations, with earnings of $0.85 per share versus $0.84 expected and revenue of $164.27 million versus $160.02 million.
  • Shares traded near $40.28, while analyst sentiment remained cautious with a consensus “Hold” rating and an average price target of $40. The company is also emphasizing AI-powered customer-experience solutions to support future growth.
  • Five stocks to consider instead of IBEX.

IBEX Limited (NASDAQ:IBEX - Get Free Report) insider Paul Inson sold 2,500 shares of the firm's stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $40.07, for a total transaction of $100,175.00. Following the completion of the sale, the insider owned 27,224 shares of the company's stock, valued at approximately $1,090,865.68. This trade represents a 8.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Paul Joseph Inson also recently made the following trade(s):

  • On Monday, September 14th, Paul Inson sold 2,274 shares of IBEX stock. The stock was sold at an average price of $40.00, for a total value of $90,960.00.

IBEX Trading Down 1.3%

Shares of IBEX traded down $0.52 during midday trading on Wednesday, hitting $40.28. 291,941 shares of the company's stock traded hands, compared to its average volume of 125,513. IBEX Limited has a 1 year low of $25.94 and a 1 year high of $42.40. The firm's fifty day moving average is $36.26 and its 200-day moving average is $31.97. The stock has a market capitalization of $534.92 million, a price-to-earnings ratio of 12.87 and a beta of 0.72.

IBEX (NASDAQ:IBEX - Get Free Report) last announced its earnings results on Thursday, September 10th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.01. IBEX had a return on equity of 28.96% and a net margin of 7.19%.The firm had revenue of $164.27 million for the quarter, compared to the consensus estimate of $160.02 million.

Key Stories Impacting IBEX

Here are the key news stories impacting IBEX this week:

  • Positive Sentiment: IBEX announced that it won a 2026 Globee Award for excellence in an AI-powered customer-experience solution. The recognition supports the company’s positioning in the growing AI-enabled business-process-outsourcing market. ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence
  • Positive Sentiment: Recent reports highlight IBEX’s efforts to use AI solutions to gain market share and adjust its delivery mix between nearshore and offshore operations. These initiatives could improve scalability, service capabilities and margins if executed successfully. IBEX touts AI solutions to grow market share IBEX shifts from nearshore to offshore
  • Positive Sentiment: IBEX’s latest quarterly results modestly exceeded expectations, with earnings per share of $0.85 versus an $0.84 consensus and revenue of $164.27 million versus estimates of $160.02 million. The company reported a 7.19% net margin and 28.96% return on equity.
  • Neutral Sentiment: Analyst sentiment remains cautious: Robert W. Baird raised its price target to $40 but kept a neutral rating, while the consensus rating is “Hold” with an average target of $40. The stock’s recent advance has placed it close to that consensus valuation.
  • Negative Sentiment: Multiple insiders sold shares around $39.34–$40.41, including CEO Robert Dechant, COO David Afdahl, directors Mingzhe Zhuang and Daniella Ballou-Aares, and other insiders. The sales totaled more than 56,000 shares across the disclosed transactions and reduced several holdings substantially, creating a negative insider-ownership signal. Some transactions, including sales by Dechant, Afdahl and Paul Inson, were made under pre-arranged Rule 10b5-1 plans. SEC insider transaction filing

Institutional Trading of IBEX

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Tieton Capital Management LLC purchased a new stake in IBEX during the second quarter worth $8,353,000. Globeflex Capital L P purchased a new position in IBEX in the second quarter valued at $3,112,000. Y Intercept Hong Kong Ltd raised its position in shares of IBEX by 121.8% in the first quarter. Y Intercept Hong Kong Ltd now owns 95,665 shares of the company's stock worth $2,566,000 after acquiring an additional 52,526 shares during the period. Lazard Asset Management LLC raised its position in shares of IBEX by 55.2% in the first quarter. Lazard Asset Management LLC now owns 89,150 shares of the company's stock worth $2,391,000 after acquiring an additional 31,697 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of IBEX by 7.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company's stock worth $9,607,000 after acquiring an additional 24,942 shares in the last quarter. Institutional investors and hedge funds own 81.24% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on IBEX. Robert W. Baird upped their price objective on shares of IBEX from $35.00 to $40.00 and gave the company a "neutral" rating in a report on Friday, September 11th. Wall Street Zen cut shares of IBEX from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of IBEX in a research report on Friday, July 31st. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $40.00.

Check Out Our Latest Research Report on IBEX

About IBEX

(Get Free Report)

IBEX Limited NASDAQ: IBEX is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.

The company's services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.

IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.

See Also

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IBEX Right Now?

Before you consider IBEX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.

While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines